2026-01-15
converted| Metric | Control | Treatment | Lift | CI (95%) | P-value | Significant | Effect Size |
|---|---|---|---|---|---|---|---|
converted |
0.9178 | 0.916 | -0.2% | [-0.0218, 0.0182] | 0.3405 | No | -0.0065 |
response_quality_score |
8.98 | 8.86 | -1.3% | [-0.42, 0.18] | 0.15 | No | -0.0584 |
latency_ms |
1128.0 | 948.0 | -15.96% | [-230.0, -130.0] | 0.01 | Yes | -0.36 |
| Segment | Control Rate | Treatment Rate | Lift | Sample Size | Significant |
|---|---|---|---|---|---|
free |
0.9072 | 0.9053 | -0.2% | 50079 | No |
enterprise |
0.9634 | 0.954 | -0.98% | 3645 | No |
pro |
0.9281 | 0.9299 | +0.2% | 31898 | No |
| Segment | Control Rate | Treatment Rate | Lift | Sample Size | Significant |
|---|---|---|---|---|---|
creative_writing |
0.9082 | 0.9109 | +0.29% | 21315 | No |
qa |
0.9462 | 0.9457 | -0.06% | 21619 | No |
code_generation |
0.9081 | 0.9002 | -0.87% | 21322 | No |
text_summarization |
0.9085 | 0.9069 | -0.18% | 21366 | No |
| Segment | Control Rate | Treatment Rate | Lift | Sample Size | Significant |
|---|---|---|---|---|---|
LATAM |
0.9147 | 0.9167 | +0.22% | 21497 | No |
EU |
0.9155 | 0.9181 | +0.29% | 21687 | No |
NA |
0.9197 | 0.9148 | -0.53% | 21269 | No |
APAC |
0.9212 | 0.9143 | -0.75% | 21169 | No |